Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-03-24 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
2023年度独立董事述职报告（肖岳峰）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report for the year 2023" from Shenzhen Huitai Medical Devices Co., Ltd. It details the independent director's duties, attendance at board meetings, oversight of audit processes, review of financial reports, and opinions on various corporate governance matters during the year. The content focuses on the independent director's activities and opinions rather than presenting full financial statements or audit results. It is a report on the independent director's annual work and governance oversight, not a full annual report, audit report, or financial statement. This type of document is best classified under Board/Management Information (MANG) as it relates to board-level governance and management oversight information.
2024-03-24 Chinese
董事会对独立董事2023年度独立性自查情况的专项报告
Board/Management Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence self-assessment of independent directors for the year 2023. It references regulatory guidelines related to independent directors and confirms compliance with independence requirements. The document is short (407 characters) and focuses on governance and board-related information rather than financial data or voting results. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Board/Management Information (MANG), which covers announcements related to board or senior management matters, including director independence assessments.
2024-03-24 Chinese
简式权益变动报告书（修订版）
Major Shareholding Notification Classification · 95% confidence The document is titled as a "简式权益变动报告书 (Simplified Equity Change Report)" and details a significant change in shareholding of Shenzhen Huitai Medical Device Co., Ltd. It includes information about the transfer of shares by a private equity fund manager to another party, the terms of the share transfer agreement, payment arrangements, and pending regulatory approvals. The document is comprehensive and contains detailed information about the shareholding change, including percentages, parties involved, and legal declarations. It is not an announcement of a report publication but the report itself. The content aligns with the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. Therefore, the appropriate classification is MRQ with high confidence.
2024-03-14 Chinese
关于股东权益变动的进展公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from Shenzhen Huitai Medical Equipment Co., Ltd. regarding progress in changes to shareholder equity. It references previous announcements about shareholder equity changes and control changes, and details a supplementary agreement related to share transfer agreements involving private equity fund managers and securities accounts. The document is short (1210 characters) and focuses on shareholder equity changes and share transfer agreements, without containing financial statements or detailed financial data. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or shareholder equity changes. It is not an annual report, earnings release, or other financial report, nor is it a simple report publication announcement or regulatory filing. Therefore, the classification is MRQ with high confidence.
2024-03-14 Chinese
关于变更签字注册会计师的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding the change of the signing certified public accountant for the company's 2023 financial audit. It details the replacement of the project partner and signing CPA due to rotation requirements, provides background on the new CPA, and confirms no impact on the audit work. The document does not contain the audit report itself or financial data but is a formal notification about a change in auditors. This fits the category of Audit Report / Information (AR), which includes standalone audit-related announcements and information about auditors, excluding full annual reports. The document length is short (1392 characters), but it is not merely a report publication announcement or certification letter; it is a substantive announcement about auditor changes. FY 2023
2024-03-05 Chinese
2023年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled '2023 年度业绩快报公告' which translates to '2023 Annual Performance Express Report Announcement'. It contains preliminary financial data for the year 2023, including revenue, profit, and earnings per share, but explicitly states that the data is preliminary, unaudited, and subject to the final audited annual report. The document is relatively short (1895 characters) and serves as a quick earnings update rather than a full annual report. This matches the characteristics of an Earnings Release (ER), which provides initial key financial highlights for a fiscal period. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks comprehensive financial statements and detailed analysis. It is also not a Report Publication Announcement (RPA) because it contains substantive financial data, not just a notice of report availability. Therefore, the correct classification is Earnings Release (ER). FY 2023
2024-02-23 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.